09:00-10:30
Educational Program
CONTROVERSY IN FERTILITY PRESERVATION FOR CANCER AND BEYOND
Session
FERTILITY PRESERVATION FOR CANCER SURVIVORS AND BEYOND
Capsule

Male and female fertility preservation became a potent tool option not only for cancer survivors but also for the current delay in family planning or, so called "social freezing"

Chairpersons

Dominique De Ziegler, France
Rita Vassena, Spain
Zion Ben-Rafael, Israel

09:00-09:20

Recent advances and new frontier in vitrification 
Laura Rienzi, Italy 

09:20-09:45

Cryopreservation of oocytes and ovarian tissue
Simon Fishel, UK

09:45-10:05

Prepubertal germ cell storage for later transplantation
Dorien Van Saen, Belgium

10:05-10:30

Preservation of fertility by uterine transplantation: Who are the candidates and what results can be expected?
Mats Brännström, Liza Johannesson, Sweden


10:50-12:20
SOCIAL FREEZING: GOOD OR BAD NEWS FOR WOMEN?
Capsule

It seems that social freezing is not synchronized with the need for it.  While social freezing is better done before age 35, women in that age group still hope to conceive spontaneously or with treatment. Is it a good solution for the wrong age group?

Chairpersons

Simon Fishel, UK
Tina Buchholz, Germany

10:50-11:10

Fundamental cryobiology for clinical embryologists
Barry Fuller, UK

11:10-11:35

Oocyte cryopreservation techniques and factors associated with survival and viability
Giovanni Coticchio, Italy

 

11:35-12:20
11:35-11:50
11:50-12:05
12:05-12:20

 
Debate: Social freezing or simply donor eggs
Social freezing: Juan Garcias Velasco, Spain
Donor eggs: Gab Kovacs, Australia 
Discussion
 

14:50-16:20
IMPLANTATION 
 
 
 Implantation failure can occur due to many reasons.  It's the most crucial step and very little is known about why implantation fails so often
14:50-15:10
Lab-technologies needed to maximize success 
Laura Rienzi, Italy

15:10-15:35 Implantation failure: The lab point of view
Tina Buchholz, Germany

15:35-15:55
Implantation failure: The clinician point of view 
Dominique De Ziegler, France
15:55-16:20
Improving implantation by "freeze all and later transfer," is it now proven to be more efficient?
Paul Devroey, Belgium

16:40-18:10
INVASIVE PROCEDURES ON THE EMBRYO: PGS
Capsule
Different invasive procedures allow selecting and maybe improving the embryo before implantation. Are they safe?
Chairpersons

Laszlo Nanassy, Hungary 
Antonio Capalbo, Italy

16:40-17:00

Epigenetics and imprinting in ART
Tina Buchholz, Germany

17:00-17:25

The new ERA of PGS
Laura Rienzi, Italy

 
17:25-18:10

17:25-17:40

17:40-17:55
17:55-18:10
 
Debate: To maximize the outcome of IVF treatment, every embryo should undergo PGS. What are the risks?
Yes: Gab Kovacs, Australia 
No: Norbert Gleicher, USA
Discussion
 

09:00-10:30
POOR OVARIAN RESERVE
Capsule
Poor ovarian reserve is easily recognized and poorly managed. The ideal stimulation for these patients remains a great challenge for the clinician.  Is there any better solution?
Chairperson  Gab Kovacs, Australia
János Urbancsek,
 Hungary

09:00-09:45

09:00-09:15
09:15-09:30
09:30-09:45

Debate: DHEA supplementation for poor responders
No evidence only hype! : Salim Daya, Canada
Real benefit no hype! : Norbert Gleicher, USA
Discussion

09:45-10:05 Pronuclear transplantation to prevent transmission of mitochondrial DNA disease.  What are the risks?
Louise Hyslop, UK
10:05-10:30 Is there an ideal stimulation for POR?
Nicholas Zech, Austria

10:50-12:20
 METHODS FOR EMBRYO SELECTION: TOWARDS SET FOR ALL
Capsule Improved ability to select the best oocytes for fertilization and embryos for implantation will likely increase use of single embryo transfer (SET) technology in IVF. Current screening methods, while providing useful information, are far from ideal - especially when each is used alone. Can a combination of methods, including new technologies, help secure better IVF success rates?
Chairperson Bart C.J.M. Fauser, The Netherlands
10:50–11:00 Session introduction
Bart C.J.M. Fauser, The Netherlands
11:00–11:20 Methods for embryo selection: One is not enough?
Basak Balaban, Turkey
11:20–11:40 The oocyte - what does it bring? How to assess it?
Bart C.J.M. Fauser, The Netherlands
11:40–11:55 Non-invasive markers: The role of G-CSF?
Carine Munaut, Belgium
11:55–12:10 Luteal phase support and endometrial receptivity
János Urbancsek, Hungary
12:10–12:20 Summary and close
Bart C.J.M. Fauser, The Netherlands

12:30-14:00
TIME-LAPSE: BETTER INCUBATOR, NEW METHOD FOR EMBRYO SELECTION OR JUST NEW COSTLY TOOL?
Capsule Time-lapse is the new hype in embryo culture and selection.  Time-lapse provides information on the timing of cell division, fragmentation, multi-nucleation, compaction, blastulation, and more.  It also offers a list of advantages for embryo incubation like flexible gas mixture, grouping of embryos, monitoring, archiving, etc.  Is it a better incubator?  New method for embryo selection that overrides the biologists
 
Chairpersons Rene Frydman, France
Laura Rienzi, Italy
Rita Vassena, Spain


12:30-13:15


12:30-12:45

12:45-13:00
13:00-13:15

Debate: Algorithms to select embryos by time-lapse to improve pregnancy rate, is it universally applicable?
Yes: Simon Fishel, UK
No: Rita Vassena, Spain
Discussion 

13:15-14:00

13:15-13:30
13:30-13:45
13:45-14:00

Debate:Single or group culture in times of time-lapse embryo monitoring systems
Single culture: Thomas Ebner, Austria
Group culture: Peter Francsovits, Hungary 
Discussion 

14:50-16:20
PCOS: REPRODUCTION AND BEYOND 
Capsule PCOS affects all phases of life but yes, we still poorly understand this enigmatic syndrome

 Chairpersons
Zion Ben-Rafael, Israel
Philippe Bouchard, France
Eva Csajbok, Hungary
14:50-15:20 Metabolic dysfunction and its implications
Philippe Bouchard, France
15:20-15:50 Reproductive dysfunction and intervention 
Bart C.J.M. Fauser, The Netherlands
15:50-16:20
Perimenopause and management 
Rogerio Lobo, USA

16:40-18:10
Hot Controversies

RTD ON CLINICALLY AND LABORATORY RELATED CONTROVERSIES

Chairpersons

Zion Ben Rafael, Israel
Rene Frydman, France

Discussants 

Norbert Gleicher, USA
Simon Fishel, UK
Rita Vassena, Spain

 
 

Questions for the panel:

  1. Stimulation in extreme cases: Low responders
  2. Stimulation in extreme cases: PCOS
  3. Increased progesterone in the follicular phase and outcome of IVF
  4. Reversed cleavage: What did we learn so far?
  5. Is time lapse a better incubator?
  6. Should we stop doing IVM? 
  7. Should we stop “using” assisted hatching?
  8. Is it still worthwhile treating women with own eggs after age 42?